Please login to the form below

Not currently logged in
Email:
Password:

Boehringer/ Elan antibody deal

Boehringer Ingelheim has announced a partnership with Elan to develop and manufacture antibody-based therapeutics

Boehringer Ingelheim has announced a partnership with Ireland-based Elan to develop and manufacture antibody-based therapeutics.

German drugmaker, Boehringer said the global deal will see Elan lead the discovery and clinical development of antibodies, with Boehringer to take over the clinical manufacturing and regulatory filing.

"The agreement enables Elan to focus resources on discovery and the clinical progression of our science while leveraging Boehringer Ingelheim's process development and production capabilities," said Dr Johannes Roebers, head of biologic strategy, planning and operations at Elan.

Elan is a biotech with a focus on developing therapies for neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.

Financial details were not disclosed.

The partnership will make use of Boehringer's High Expression Technology (BI HEX) platform, which aims to speed up development times for biological entities, such as antibodies.

"This is a first step in our new strategy engaging our technology platforms at a very early stage in product development," said Simon Sturge, corporate senior vice president of Boehringer's biopharmaceutical division.

Dr Dale Schenk, chief scientific officer, Elan, said the partnership would increase the productivity and potential of the company's development plans for antibodies: "These programmes are broad in scope and are innovative across technology, targets and possible disease application."

10th February 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

AI and genomics: a revolution in drug discovery and development
...
Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....

Infographics